Cerus (CERS) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Cerus (CERS) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | -2.41% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 100.22% |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | 9.28% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | -35.05% |
| 10 | Cerus | 605.72 Mn | 525.30 Mn | 27.89 Mn | 65.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.32% |
| Dec 31, 2025 | 52.15% |
| Sep 30, 2025 | 29.24% |
| Jun 30, 2025 | 8.83% |
| Mar 31, 2025 | -11.33% |
| Dec 31, 2024 | 62.47% |
| Sep 30, 2024 | 50.45% |
| Jun 30, 2024 | 28.46% |
| Mar 31, 2024 | 40.04% |
| Dec 31, 2023 | 26.60% |
| Sep 30, 2023 | 9.81% |
| Jun 30, 2023 | 37.62% |
| Mar 31, 2023 | 21.94% |
| Dec 31, 2022 | 44.14% |
| Sep 30, 2022 | -62.62% |
| Jun 30, 2022 | 43.09% |
| Mar 31, 2022 | 37.32% |
| Dec 31, 2021 | 32.38% |
| Sep 30, 2021 | 58.62% |
| Jun 30, 2021 | 53.45% |